TOLEDO, Ohio–(BUSINESS WIRE)– Health Care REIT, Inc. (HCN) announced today the resignation of JohnT. Thomas, Executive Vice PresidentMedical Facilities, effective July25, 2012. Continue reading
Tag Archives: a-portfolio-and
Chatham, Baxter partner to develop and commercialize hemophilia B gene therapy treatment
Baxter International Inc. (NYSE:BAX) today announced that it has entered into an exclusive global agreement with Chatham Therapeutics, LLC, an affiliate of Asklepios BioPharmaceutical, Inc. Continue reading